SARS-CoV-2 virus up close. Antibodies and Antigens for COVID-19

Recombinant Human Monoclonal Antibodies against SARS-CoV-2 Regions

Leinco Technologies is a leader in the development and manufacturing of recombinant antibodies and proteins for early discovery research and diagnostics. In response to the ongoing worldwide pandemic, Leinco Technologies offers an extensive line of SARS-CoV-2 Antibodies and Antigens at the highest functional purity levels you have come to know and trust. SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus, which causes the coronavirus disease 2019 (COVID-19).

Leinco’s protein product offerings include Trimeric Spike protein, S1 protein, S protein RBD,  S protein NTD, Nucleocapsid protein, and more. Polyclonal antibodies include Anti-ACE2, Anti-SARS-CoV-2 Envelope, Anti-SARS-CoV-2 Spike, and more! See full list below.

Learn more about Leinco’s industry-leading purity specification and custom services. As Leinco continues to research and develop products, please contact our team to explore new development opportunities!

How can we support your research?
COVID-19 anatomy (E Protein, Spike Protein, M-Protein, RNA, N Protein, HE) and the mechanisms to entering the body

COVID-19 Diagram: ACE2 is the host cell receptor responsible for mediating infection by SARS-CoV-2, responsible for coronavirus disease 2019 (COVID-19). Anti-ACE2 antibodies or Anti-RBD antibodies disrupt the interaction between the virus and receptor.

SARS-CoV-2 Antibodies and Antigens (COVID-19, 2019-nCoV)

Polyclonal Products

Product Applications Prod. No Package Size
Anti-ACE2 (17aa – Intermediate Domain) IHC FFPE, WB A314 0.1 mg
Anti-ACE2 (CT) IHC FFPE, WB A313 0.1 mg
Anti-ACE2 (NT) IHC FFPE, WB A316 0.1 mg
Anti-ACE2 (Intermediate Domain) IHC FFPE, WB A315 0.1 mg
Anti-SARS-CoV Envelope (CT) ELISA Indirect S536 0.1 mg
Anti-SARS-CoV Matrix (NT) ELISA Indirect S539 0.1 mg
Anti-SARS-CoV Matrix (CT) ELISA Indirect S538 0.1 mg
Anti-SARS-CoV Spike (NT) ELISA Indirect S544 0.1 mg
Anti-SARS-CoV Spike (16aa – Intermediate Domain) ELISA Indirect S541 0.1 mg
Anti-SARS-CoV Spike (17aa – Intermediate Domain) ELISA Indirect S542 0.1 mg
Anti-SARS-CoV Spike (15aa – Intermediate Domain) ELISA Indirect S543 0.1 mg
Anti-SARS-CoV-2 Envelope (NT) ELISA Indirect S537 0.1 mg
Anti-SARS-CoV-2 Spike (CT) ELISA Indirect S540 0.1 mg

Recombinant Human Monoclonal Antibody Products

Product Clone Applications Prod. No Package Size
SARS-CoV-2 Spike Protein ELISA, FC Coming Soon 100 µg, 1 mg
SARS-CoV-2 Spike NTD 2146 ELISA, FC, IHC LT2000 500 µg, 100 µg, 1 mg
SARS-CoV-2 Spike RBD 2165 ELISA, FC, IHC LT1900 500 µg, 100 µg, 1 mg
SARS-CoV-2 Spike Nucleocapsid (N) ELISA, FC Coming Soon 100 µg, 1 mg
Anti-Human IgM µ-Chain Specific HB57 ELISA I-1202 0.25 mg, Custom/Bulk
Anti-Human IgG Fc Specific HP6043 ELISA I-1193 0.25 mg, Custom/Bulk

Protein Products

Product Prod. No Package Size
SARS-CoV-2 Trimeric Spike (S) protein S848 100 µg, 500 µg, 1 mg
SARS-CoV-2 S1 protein S849 100 µg, 500 µg, 1 mg
SARS-CoV-2 S2 protein Coming Soon 100 µg, 500 µg, 1 mg
SARS-CoV-2 S protein, RBD S851 100 µg, 500 µg, 1 mg
SARS-CoV-2 S protein, RBD-Fc tag Coming Soon 100 µg, 500 µg, 1 mg
SARS-CoV-2 S protein, NTD S853 100 µg, 500 µg, 1 mg
SARS-CoV-2 Nucleocapsid (N) protein Coming Soon 100 µg, 500 µg, 1 mg